“…42 Herbal therapies used to treat convulsive diseases in Asia in modern times include Chai-Hu-Long-Ku-Mu-Li-Tan (TW-001), a mixture of extracts from 13 herbal therapies; Gastrodia elata (Tian Ma; gastrodia root); Uncaria rhynchophylla (cat's claw); Menispermum dauricum (moonseed); Shitei-To, a mixture of extracts from three medicinal herbs, Shitei (kaki calyx; the calyx of Diospyros kaki persimmon), Shokyo (gingerroot; rhizome of Zingiber officinale), and Choji (clove; pharmaceutical name, caryophylli flos; the flowerbud of Syzygium aromaticum); mixture of radish (Raphanus sativus) and pepper (Piper species, containing the alkaloid piperine); Qingyangshen (root of Cynanchum otophyllum); Kanbaku-taiso-to, a mixture of three herbal drugs, glycyrrhizae radix (licorice root; Glycyrrhiza species), tritici semen (wheat seed; Triticum aestivum), and zizyphi fructus (spiny jujube fruit; Ziziphus spinosa); paeoniae radix (peony root; Paeonia lactiflora, synonym P. albiflora); and Zheng Tai instant powder (a complex prescription of traditional Chinese medicines used for tonic-clonic seizures). 43 Several of these herbal therapies have been shown to have neuroprotective properties, [44][45][46] efficacy in animal models of epilepsy [47][48][49] and hippocampal slice models, 50 and effects on gene expression. 51 These studies generally do not specify, however, the methods used to 1) authenticate the source plants, 2) produce extracts and fractions, 3) characterize the active ingredients, or 4) perform the preclinical evaluations.…”